5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis.

Czibere, A; Bruns, I; Kröger, N; Platzbecker, U; Lind, J; Zohren, F; Fenk, R; Germing, U; Schröder, T; Gräf, T; Haas, R; Kobbe, G

Czibere, A; Bruns, I; Kröger, N; Platzbecker, U; Lind, J; Zohren, F; Fenk, R; Germing, U; Schröder, T; Gräf, T; Haas, R; Kobbe, G.

Affiliation

Czibere A; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany. Akos.Czibere@med.uni-duesseldorf.de

Bone Marrow Transplant ; 45(5): 872-6, 2010 May.

Article in En | MEDLINE | ID: mdl-19820729

Subject(s)

Azacitidine/therapeutic use; Leukemia, Myeloid, Acute/therapy; Myelodysplastic Syndromes/therapy; Stem Cell Transplantation/adverse effects; Adult; Aged; Female; Graft vs Host Disease/complications; Graft vs Host Disease/drug therapy; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Analysis; Transplantation, Homologous

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2010 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google